Literature DB >> 10493777

Aldose and aldehyde reductases: structure-function studies on the coenzyme and inhibitor-binding sites.

O El-Kabbani1, S E Old, S L Ginell, D A Carper.   

Abstract

PURPOSE: To identify the structural features responsible for the differences in coenzyme and inhibitor specificities of aldose and aldehyde reductases.
METHODS: The crystal structure of porcine aldehyde reductase in complex with NADPH and the aldose reductase inhibitor sorbinil was determined. The contribution of each amino acid lining the coenzyme-binding site to the binding of NADPH was calculated using the Discover package. In human aldose reductase, the role of the non-conserved Pro 216 (Ser in aldehyde reductase) in the binding of coenzyme was examined by site-directed mutagenesis.
RESULTS: Sorbinil binds to the active site of aldehyde reductase and is hydrogen-bonded to Trp 22, Tyr 50, His 113, and the non-conserved Arg 312. Unlike tolrestat, the binding of sorbinil does not induce a change in the side chain conformation of Arg 312. Mutation of Pro 216 to Ser in aldose reductase makes the binding of coenzyme more similar to that of aldehyde reductase.
CONCLUSIONS: The participation of non-conserved active site residues in the binding of inhibitors and the differences in the structural changes required for the binding to occur are responsible for the differences in the potency of inhibition of aldose and aldehyde reductases. We report that the non-conserved Pro 216 in aldose reductase contributes to the tight binding of NADPH.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493777

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  3 in total

1.  Enzymes in pancreatic islets that use NADP(H) as a cofactor including evidence for a plasma membrane aldehyde reductase.

Authors:  M Laclau; F Lu; M J MacDonald
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

2.  Construction of an alternative glycerol-utilization pathway for improved β-carotene production in Escherichia coli.

Authors:  Jin-Ying Guo; Kun-Le Hu; Chang-Hao Bi; Qing-Yan Li; Xue-Li Zhang
Journal:  J Ind Microbiol Biotechnol       Date:  2018-05-11       Impact factor: 3.346

3.  Inhibition of Aldose Reductase by Novel Phytocompounds: A Heuristic Approach to Treating Diabetic Retinopathy.

Authors:  Angeline Julius; Remya Rajan Renuka; Waheeta Hopper; P Babu Raghu; Sharmila Rajendran; Senthilkumari Srinivasan; Kuppamuthu Dharmalingam; Amer M Alanazi; Selvaraj Arokiyaraj; S Prasath
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-21       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.